Logo image of ACX.DE

BET-AT-HOME.COM AG (ACX.DE) Stock Fundamental Analysis

Europe - FRA:ACX - DE000A0DNAY5 - Common Stock

2.55 EUR
-0.04 (-1.54%)
Last: 11/6/2025, 7:00:00 PM
Fundamental Rating

3

ACX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 53 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for ACX as it has an excellent financial health rating, but there are worries on the profitability. ACX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACX had negative earnings in the past year.
In the past year ACX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACX reported negative net income in multiple years.
Of the past 5 years ACX 4 years had a positive operating cash flow.
ACX.DE Yearly Net Income VS EBIT VS OCF VS FCFACX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of ACX (-12.04%) is worse than 77.36% of its industry peers.
The Return On Equity of ACX (-25.45%) is worse than 60.38% of its industry peers.
Industry RankSector Rank
ROA -12.04%
ROE -25.45%
ROIC N/A
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ACX.DE Yearly ROA, ROE, ROICACX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

ACX's Operating Margin has declined in the last couple of years.
ACX's Gross Margin of 78.75% is amongst the best of the industry. ACX outperforms 81.13% of its industry peers.
In the last couple of years the Gross Margin of ACX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ACX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.75%
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
ACX.DE Yearly Profit, Operating, Gross MarginsACX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

ACX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACX remains at a similar level compared to 1 year ago.
ACX has about the same amout of shares outstanding than it did 5 years ago.
ACX has a better debt/assets ratio than last year.
ACX.DE Yearly Shares OutstandingACX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ACX.DE Yearly Total Debt VS Total AssetsACX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 2.42 indicates that ACX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ACX (2.42) is better than 71.70% of its industry peers.
The Debt to FCF ratio of ACX is 1.78, which is an excellent value as it means it would take ACX, only 1.78 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.78, ACX belongs to the best of the industry, outperforming 84.91% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that ACX is not too dependend on debt financing.
The Debt to Equity ratio of ACX (0.04) is better than 92.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.78
Altman-Z 2.42
ROIC/WACCN/A
WACC7.03%
ACX.DE Yearly LT Debt VS Equity VS FCFACX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.61 indicates that ACX should not have too much problems paying its short term obligations.
ACX's Current ratio of 1.61 is amongst the best of the industry. ACX outperforms 96.23% of its industry peers.
ACX has a Quick Ratio of 1.61. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.61, ACX belongs to the top of the industry, outperforming 96.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61
ACX.DE Yearly Current Assets VS Current LiabilitesACX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for ACX have decreased strongly by -76.17% in the last year.
ACX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.31%.
Measured over the past years, ACX shows a very negative growth in Revenue. The Revenue has been decreasing by -18.26% on average per year.
EPS 1Y (TTM)-76.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%185.44%
Revenue 1Y (TTM)12.31%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%-0.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACX.DE Yearly Revenue VS EstimatesACX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
ACX.DE Yearly EPS VS EstimatesACX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACX. In the last year negative earnings were reported.
ACX is valuated cheaply with a Price/Forward Earnings ratio of 4.07.
Based on the Price/Forward Earnings ratio, ACX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 31.86, ACX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.07
ACX.DE Price Earnings VS Forward Price EarningsACX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ACX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 25.39
EV/EBITDA N/A
ACX.DE Per share dataACX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ACX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACX!.
Industry RankSector Rank
Dividend Yield N/A

BET-AT-HOME.COM AG

FRA:ACX (11/6/2025, 7:00:00 PM)

2.55

-0.04 (-1.54%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)09-23 2025-09-23
Earnings (Next)11-05 2025-11-05
Inst Owners0.21%
Inst Owner ChangeN/A
Ins Owners58.83%
Ins Owner ChangeN/A
Market Cap17.90M
Revenue(TTM)77.97M
Net Income(TTM)-6.31M
Analysts80
Price Target5.61 (120%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.52%
PT rev (3m)-18.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.07
P/S 0.23
P/FCF 25.39
P/OCF 25.07
P/B 0.72
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)0.63
Fwd EY24.56%
FCF(TTM)0.1
FCFY3.94%
OCF(TTM)0.1
OCFY3.99%
SpS11.11
BVpS3.53
TBVpS3.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.04%
ROE -25.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.75%
FCFM 0.9%
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.78
Debt/EBITDA N/A
Cap/Depr 0.94%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 2.42
F-Score4
WACC7.03%
ROIC/WACCN/A
Cap/Depr(3y)22.88%
Cap/Depr(5y)42.26%
Cap/Sales(3y)0.89%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%185.44%
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.31%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%-0.27%
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.02%
EBIT growth 3Y-59.94%
EBIT growth 5Y-53.14%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.26%
FCF growth 3Y-55.42%
FCF growth 5Y-51.16%
OCF growth 1Y-88.03%
OCF growth 3Y-57.74%
OCF growth 5Y-51.62%

BET-AT-HOME.COM AG / ACX.DE FAQ

Can you provide the ChartMill fundamental rating for BET-AT-HOME.COM AG?

ChartMill assigns a fundamental rating of 3 / 10 to ACX.DE.


What is the valuation status of BET-AT-HOME.COM AG (ACX.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to BET-AT-HOME.COM AG (ACX.DE). This can be considered as Fairly Valued.


How profitable is BET-AT-HOME.COM AG (ACX.DE) stock?

BET-AT-HOME.COM AG (ACX.DE) has a profitability rating of 2 / 10.


What is the financial health of BET-AT-HOME.COM AG (ACX.DE) stock?

The financial health rating of BET-AT-HOME.COM AG (ACX.DE) is 7 / 10.